{"id":"d-0502","safety":{"commonSideEffects":[{"rate":null,"effect":"unknown"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by binding to the molecular target, which results in the desired therapeutic effect. This mechanism of action is still being researched and understood.","oneSentence":"D-0502 is a small molecule that targets the molecular target.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:08:29.718Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Phase 3 for unspecified indication"}]},"trialDetails":[{"nctId":"NCT07336771","phase":"PHASE1, PHASE2","title":"JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Alphamab Biopharmaceuticals Co., Ltd","startDate":"2026-01","conditions":"Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC)","enrollment":60},{"nctId":"NCT06954961","phase":"PHASE3","title":"A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer","status":"RECRUITING","sponsor":"InventisBio Co., Ltd","startDate":"2022-09-15","conditions":"Breast Cancer","enrollment":640},{"nctId":"NCT03471663","phase":"PHASE1","title":"A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer","status":"COMPLETED","sponsor":"InventisBio Co., Ltd","startDate":"2018-03-18","conditions":"Breast Cancer","enrollment":200},{"nctId":"NCT05339633","phase":"PHASE1","title":"Study in Healthy Adult Female Subjects","status":"COMPLETED","sponsor":"InventisBio Co., Ltd","startDate":"2022-03-29","conditions":"Mass Balance Recovery","enrollment":8},{"nctId":"NCT05226338","phase":"PHASE1","title":"Evaluation of Relative Bioavailability of D-0502 Tablet in Healthy Female Subjects","status":"COMPLETED","sponsor":"InventisBio Co., Ltd","startDate":"2021-10-27","conditions":"Healthy Female Volunteer","enrollment":18},{"nctId":"NCT03810625","phase":"PHASE1","title":"Food Effect Study of D-0502 Tablet in Healthy Volunteers","status":"COMPLETED","sponsor":"InventisBio Co., Ltd","startDate":"2018-10-23","conditions":"Breast Cancer","enrollment":14}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ACUTE KIDNEY INJURY"},{"count":1,"reaction":"DIZZINESS"},{"count":1,"reaction":"OBSTRUCTIVE PANCREATITIS"},{"count":1,"reaction":"PNEUMONIA"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"D-0502","genericName":"D-0502","companyName":"InventisBio Co., Ltd","companyId":"inventisbio-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"D-0502 is a small molecule that targets the molecular target. Used for Phase 3 for unspecified indication.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}